 |
|
Prevalence of HPV Infection Among Females in the United States
Eileen F. Dunne, MD, MPH;
Elizabeth R. Unger, PhD, MD;
Maya Sternberg, PhD;
Geraldine McQuillan, PhD;
David C. Swan, PhD;
Sonya S. Patel, BS;
Lauri E. Markowitz, MD
JAMA. 2007;297:813-819.
Context Human papillomavirus (HPV) infection is estimated to be the most common sexually transmitted infection. Baseline population prevalence data for HPV infection in the United States before widespread availability of a prophylactic HPV vaccine would be useful.
Objective To determine the prevalence of HPV among females in the United States.
Design, Setting, and Participants The National Health and Nutrition Examination Survey (NHANES) uses a representative sample of the US noninstitutionalized civilian population. Females aged 14 to 59 years who were interviewed at home for NHANES 2003-2004 were examined in a mobile examination center and provided a self-collected vaginal swab specimen. Swabs were analyzed for HPV DNA by L1 consensus polymerase chain reaction followed by type-specific hybridization. Demographic and sexual behavior information was obtained from all participants.
Main Outcome Measures HPV prevalence by polymerase chain reaction.
Results The overall HPV prevalence was 26.8% (95% confidence interval [CI], 23.3%-30.9%) among US females aged 14 to 59 years (n = 1921). HPV prevalence was 24.5% (95% CI, 19.6%-30.5%) among females aged 14 to 19 years, 44.8% (95% CI, 36.3%-55.3%) among women aged 20 to 24 years, 27.4% (95% CI, 21.9%-34.2%) among women aged 25 to 29 years, 27.5% (95% CI, 20.8%-36.4%) among women aged 30 to 39 years, 25.2% (95% CI, 19.7%-32.2%) among women aged 40 to 49 years, and 19.6% (95% CI, 14.3%-26.8%) among women aged 50 to 59 years. There was a statistically significant trend for increasing HPV prevalence with each year of age from 14 to 24 years (P<.001), followed by a gradual decline in prevalence through 59 years (P = .06). HPV vaccine types 6 and 11 (low-risk types) and 16 and 18 (high-risk types) were detected in 3.4% of female participants; HPV-6 was detected in 1.3% (95% CI, 0.8%-2.3%), HPV-11 in 0.1% (95% CI, 0.03%-0.3%), HPV-16 in 1.5% (95% CI, 0.9%-2.6%), and HPV-18 in 0.8% (95% CI, 0.4%-1.5%) of female participants. Independent risk factors for HPV detection were age, marital status, and increasing numbers of lifetime and recent sex partners.
Conclusions HPV is common among females in the United States. Our data indicate that the burden of prevalent HPV infection among females was greater than previous estimates and was highest among those aged 20 to 24 years. However, the prevalence of HPV vaccine types was relatively low.
Author Affiliations: Centers for Disease Control and Prevention, Atlanta, Ga (Drs Unger and Swan, and Ms Patel); and National Center for Health Statistics, Centers for Disease Control and Prevention, Bethesda, Md (Dr McQuillan).
RELATED LETTERS
HPV Prevalence and Transmission
Tyler Cymet
JAMA. 2007;298(1):38.
EXTRACT
| FULL TEXT
HPV Prevalence and Transmission—Reply
Eileen Dunne and Lauri Markowitz
JAMA. 2007;298(1):38.
EXTRACT
| FULL TEXT
RELATED ARTICLES
HPV Prevalence and Transmission—Reply
Eileen Dunne and Lauri Markowitz
JAMA. 2007;298(1):38.
EXTRACT
| FULL TEXT
Estimating the Population Prevalence of HPV
Susan C. Weller and Lawrence R. Stanberry
JAMA. 2007;297(8):876-878.
EXTRACT
| FULL TEXT
Human Papillomavirus Infection
Janet M. Torpy, Alison E. Burke, and Richard M. Glass
JAMA. 2007;297(8):912.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Pilot Study of Prevalence of High-Risk Human Papillomavirus Genotypes in Israeli Jewish Women Referred for Colposcopic Examination
Grisaru et al.
J. Clin. Microbiol. 2008;46:1602-1605.
ABSTRACT
| FULL TEXT
Rates of Human Papillomavirus Vaccination, Attitudes About Vaccination, and Human Papillomavirus Prevalence in Young Women
Kahn et al.
Obstet Gynecol 2008;111:1103-1110.
ABSTRACT
| FULL TEXT
Rapid Clearance of Human Papillomavirus and Implications for Clinical Focus on Persistent Infections
Rodriguez et al.
JNCI J Natl Cancer Inst 2008;100:513-517.
ABSTRACT
| FULL TEXT
Seroprevalences of Herpes Simplex Virus Type 2, Five Oncogenic Human Papillomaviruses, and Chlamydia trachomatis in Katowice, Poland
Gorander et al.
CVI 2008;15:675-680.
ABSTRACT
| FULL TEXT
Human Papillomavirus Infection and Cervical Cytology in Women Screened for Cervical Cancer in the United States, 2003-2005
Datta et al.
ANN INTERN MED 2008;148:493-500.
ABSTRACT
| FULL TEXT
Human Papillomavirus Infections in Primary Care
Ogunmodede et al.
Clin Med Res 2007;5:210-217.
ABSTRACT
| FULL TEXT
Demographic and Pathologic Differences in the Incidence of Invasive Penile Cancer in the United States, 1995-2003
Goodman et al.
Cancer Epidemiol. Biomarkers Prev. 2007;16:1833-1839.
ABSTRACT
| FULL TEXT
Additional Health Care Visits Needed Among Adolescents for Human Papillomavirus Vaccine Delivery Within Medical Homes: A National Study
Rand et al.
Pediatrics 2007;120:461-466.
ABSTRACT
| FULL TEXT
HPV Vaccines Prophylactic, Not Therapeutic
Markowitz
JAMA 2007;298:805-806.
FULL TEXT
HPV Prevalence and Transmission
Cymet
JAMA 2007;298:38-38.
FULL TEXT
Sociodemographic Factors Associated With High-Risk Human Papillomavirus Infection
Kahn et al.
Obstet Gynecol 2007;110:87-95.
ABSTRACT
| FULL TEXT
JournalWatch
Arch. Dis. Child. 2007;92:650-651.
FULL TEXT
Mandatory HPV Vaccination: Public Health vs Private Wealth
Gostin and DeAngelis
JAMA 2007;297:1921-1923.
FULL TEXT
Circumcision in the Time of HIV: When Is There Enough Evidence to Revise the American Academy of Pediatrics' Policy on Circumcision?
Dickerman
Pediatrics 2007;119:1006-1007.
FULL TEXT
Life saving treatment or giant experiment?
Coombes
BMJ 2007;334:721-723.
FULL TEXT
HPV Infection in U.S. Women: Who Has the Highest Prevalence?
JWatch Women's Health 2007;2007:3-3.
FULL TEXT
Human Papillomavirus Prevalence in the U.S.
JWatch Pediatrics 2007;2007:1-1.
FULL TEXT
High Prevalence of HPV in U.S. Females
JWatch Emergency Med. 2007;2007:2-2.
FULL TEXT
HPV Prevalence in U.S. Women
JWatch General 2007;2007:1-1.
FULL TEXT
Estimating the Population Prevalence of HPV
Weller and Stanberry
JAMA 2007;297:876-878.
FULL TEXT
|
